NCT05520346 Testing a Device for Automatically TRacking Urine and STool in an Inpatient HCT Setting (Project TRUST)
| NCT ID | NCT05520346 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Duke University |
| Condition | Fluid Output |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2023-09-13 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2023-09-13 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine whether a prototype toilet device that we have developed can accurately and automatically track human fluid output from renal and gastrointestinal systems in the hospital. The device includes components that can be outfitted onto existing toilets. In this study, participants hospital room will be outfitted with the prototype toilet device. Participants will use the toilet as usual throughout the duration of their inpatient stay. Sometimes output will be measured by the device, and other times output will be measured manually by nurses.
Eligibility Criteria
Inclusion Criteria: * Scheduled to undergo an allogeneic or autologous hematopoietic stem cell transplant for any cancer or non-cancer illness through the Duke ABMT clinic * Age 18-80 years * Karnofsky Performance Scale KPS ≥ 70 * Able to read/write English Exclusion Criteria: * Inability to use toilet device due to physical constraints, e.g. waste excreted through stoma or catheter * Physician recommendation that patient does not use standard urine/stool collection hat during days 1-2 of HCT conditioning
Contact & Investigator
Chenyu Lin, MD
PRINCIPAL INVESTIGATOR
Duke University
Frequently Asked Questions
Who can join the NCT05520346 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Fluid Output. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05520346 currently recruiting?
Yes, NCT05520346 is actively recruiting participants. Contact the research team at lauren.hill@duke.edu for enrollment information.
Where is the NCT05520346 trial being conducted?
This trial is being conducted at Durham, United States.
Who is sponsoring the NCT05520346 clinical trial?
NCT05520346 is sponsored by Duke University. The principal investigator is Chenyu Lin, MD at Duke University. The trial plans to enroll 54 participants.